The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a alike therapeutic https://socialmediatotal.com/story5752404/retatrutide-vs-tirzepatide-a-comparative-analysis